Results 1 to 10 of about 230,556 (169)

Mouse Model of Graves' Orbitopathy in Current Research and Future Perspectives. [PDF]

Medicina (Kaunas)
Lee GM, Jung WH, Kim Y, Oh MI, Jang SY.
europepmc   +1 more source

Sirolimus for the treatment of Graves' orbitopathy. [PDF]

Thyroid Res
Comi S, Sabini E, Cosentino G, Santini F, Marinò M.   +4 more
europepmc   +1 more source

Dipeptidyl peptidase-4 inhibitors suppress myofibroblastic differentiation and hyaluronan synthesis in Graves' orbitopathy fibroblasts. [PDF]

Front Endocrinol (Lausanne)
Shih CW, Tsai FC, Shih SR, Liao SL, Chu I, Hong TM, Liao NL, Wei YH.   +7 more
europepmc   +1 more source

Development of Graves orbitopathy after thyroidectomy for thyroid cancer. [PDF]

JCEM Case Rep
Hormiz M, Sydenham-Clarke L, Lammoza N, Zajac JD, Grossmann M, Lau LH.   +5 more
europepmc   +1 more source

Efficacy and safety of tocilizumab in the treatment of Graves' orbitopathy: a systematic review and meta-analysis. [PDF]

BMC Endocr Disord
Chen J, Chen Y, Huang H, Duan H.
europepmc   +1 more source

Assessment of disease activity in Graves' orbitopathy. [PDF]

Front Ophthalmol (Lausanne)
Potvin ARGG, Lacraru IC, Bisschop PH, de Win MML, Eckstein AK, Saeed P.   +5 more
europepmc   +1 more source

Unilateral proptosis as the manifestation of euthyroid Graves orbitopathy: A case report. [PDF]

Medicine (Baltimore)
Rauniyar S, Pokhrel M, Dhenga S, Chaudhary G, Shrestha B.   +4 more
europepmc   +1 more source

<i>In vitro</i> evaluation of the interaction between orbital fibroblasts and PBMCs from Graves' orbitopathy patients in triggering periorbital remodeling. [PDF]

Front Immunol
Starosz A, Dik WA, Paridaens D, van Holten Neelen JCPA, Goes S, Pawłowski P, Grubczak K.   +6 more
europepmc   +1 more source

Complications after radiotherapy in patients with Graves' orbitopathy: A nationwide cohort study. [PDF]

Eye (Lond)
Lee J, Ahn HY, Heo JS, Kim M, Lee JK.
europepmc   +1 more source

Selenium Supplementation in Graves' Orbitopathy: Effects on Blood Concentrations and Clinical Outcomes. [PDF]

Clin Ophthalmol
Lumyongsatien M, Vejsitthangkul K, Treebuppachatsakul T, Sintuwong S, Nimitwongsakul O, Pongpirul K.   +5 more
europepmc   +1 more source